Dr. Wale joined VIHA from the UK in May 2009 to take an Island-wide portfolio including quality, patient safety, infection prevention, and research. Martin qualified in medicine from Nottingham, UK, and trained in medical microbiology in the Public Health Laboratory Service. After appointment as Consultant he worked in university hospitals in Southampton and Nottingham. In 2007 he was awarded a Fellowship to the NHS Institute for Innovation and Improvement, working on novel approaches to managing Clostridium difficile associated disease (CDAD), and was appointed Special Associate Professor at Nottingham University Medical School. Martin achieved Distinction in his Executive MBA in 2008. Prior to coming to Canada he was Chief Medical Officer at a large multi-site Acute Trust in the NHS. His research interests include antimicrobial resistance and sustainable system improvement.
- Member of the Royal College of Pathologists
- Fellow of the Royal College of Pathologists
- Master of Business Administration with Distinction, Nottingham University Business School. 2008
- Diploma in Bacteriology, University of Manchester. 1988
- Bachelor of Medicine, Bachelor of Surgery, University of Nottingham Medical School. 1980
- Bachelor of Medical Sciences (Honours) (Pathology) 2(i), University of Nottingham Medical School. 1978
- Barnes RO, Holmes BJ, Lindstrom RR, Trytten C, Wale MCJ. Evidence-informed health care through integration of health research: the case for breaking down the silos. Healthcare Management Forum. January 28, 2015, doi: 10.1177/0840470414562637.
- Johnson AP, Lamagni TL, Wale M, Cavendish S, Bishop L, Alhaddad N, Warner M, Livermore DM, Duckworth G, George RC. Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003. International Journal of Antimicrobial Agents. 2005 Jun;25(6):539-41. CA.
- Thornton R, Court B, Meara J, Murray V, Palmer I, Scott R, Wale M, Wright D. Chemical, biological, radiological and nuclear terrorism: an introduction for occupational physicians. Occupational Medicine (London). 2004 Mar;54(2):101-9. Review. CA.
- Price DB, Honeybourne D, Little P, Mayon-White RT, Read RC, Thomas M, Wale MC, FitzGerald P, Weston AR, Winchester CC. Community-acquired pneumonia mortality: a potential link to antibiotic prescribing trends in general practice. Respiratory Medicine. 2004 Jan;98(1):17-24.
- Enstone J, Wale MCJ, Nguyen-Van-Tam, J. Adverse medical events in British service personnel following anthrax vaccination. Vaccine 2003; 21: 1348-1354. SA.
- Braid JJ, Wale MC. The antibacterial activity of triclosan-impregnated storage boxes against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus and Shewanella putrefaciens in conditions simulating domestic use. J Antimicrob Chemother 2002; 49(1): 87-94. SA.
- Johnson AP, Aucken HM, Cavendish S, Ganner M, Wale MC, Warner M, Livermore DM, Cookson BD, UK EARSS Participants. Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). J Antimicrob Chemother. 2001;48(1):143-144.
- Reacher MH, Shah A, Livermore DM, Wale MC, Graham C, Johnson AP, Heine H, Monnickendam MA, Barker KF, James D, George RC. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. Brit Med J. 2000;320(7229):213-6. CA.
- Neal KR, Nguyen-Van-Tam JS, Jeffrey N, Slack RC, Madeley RJ, Ait-Tahar K, Job K, Wale MC, Ala’Aldeen DA. Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study. Brit Med J. 2000;320(7238):846-9. CA.
- Goettsch W, Bronzwaer SL, de Neeling AJ, Wale MC, Aubry-Damon H, Olsson-Liljequist B, Sprenger MJ, Degener JE. Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European Antimicrobial Resistance Surveillance System (EARSS). Clin Microbiol Infect. 2000;6(2):59-63. CA.
Microbiology, antimicrobial resistance and its epidemiology